MedCity News May 24, 2022
Raj Indupuri

To achieve diversity goals in research requires a multifaceted approach that makes clinical trial participation easier and uses analytics to help identify the right patients to recruit for a clinical trial.

One of the greatest challenges facing clinical trials today is the timely recruitment of participants, with 40% of cancer trials failing to reach targets for accrual. The reasons for this include, but are not limited to, a lack of awareness and education about the option to be in research trials, limited proximity to research sites, and an inability to participate due to the impact of the protocol requirements on daily life already burdened by disease.

These obstacles have helped energize the decentralized clinical trials (DCT) movement catalyzed by Covid-19,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Analytics, Big Data, Biotechnology, Clinical Trials, Pharma / Biotech, Technology, Trends
Cerevance raises $47m to fund Phase III trial for lead Parkinson’s therapy
Parexel strikes deal with Palantir for clinical trial AI
Risklick debuts new AI software that writes clinical trial protocols
“Intentional effort” needed from sponsors to achieve diversity in oncology clinical trials
It’s Time to Give Patients a Seat at the Table

Share This Article